← Eichor
Study identifier: NCT07018960 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

"Multicenter Registry for Chest Wall Reconstruction Using Custom Dynamic Prostheses (PRODIPET)"

Condition: Chest Wall Tumors · Post-traumatic Syndrome · Malignant Bone Tumor of Chest Wall  ·  Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

PRODIPET Study Summary Title: Multicenter Registry for Chest Wall Reconstruction Using Custom 3D-Printed Titanium Prostheses Purpose The PRODIPET study evaluates the safety and effectiveness of personalized, dynamic titanium prostheses for reconstructing the chest wall after: Tumor resection (e.g., sarcomas, lung cancer). Severe trauma (e.g., multiple rib fractures). Traditional methods (metal plates, mesh) often lack flexibility, potentially causing pain or breathing difficulties. This study tests 3D-printed titanium implants designed to mimic natural rib movement, improving function and comfort. Study Design Type: Multicenter, ambispective (retrospective + prospective data). Duration: Prospective: 24 months (Jan 2024-Jan 2026). Follow-up: 12 months per patient (final analysis by 2027). Centers: Major Spanish hospitals (Ramón y Cajal/Madrid, La Ribera/Alzira, Cruces/Baracaldo, Insular/Las Palmas). Key Goals Assess short/mid-term outcomes (pain, breathing, complications). Compare results across patients/surgical techniques. Improve future prosthesis designs. Who Can Participate? Inclusion: Adults (18+) needing chest wall reconstruction. Signed consent for anonymized data sharing. Exclusion: Titanium allergies. Participation in conflicting studies. Patient Experience Pre-Surgery: CT scan creates a custom 3D prosthesis (made by Osteobionix® using Ti6AL4V-ELI titanium). Surgery: Surgeons implant the prosthesis, anchoring it to ribs/sternum. Follow-Up: Evaluat…

This description comes directly from the study's public registry record.

Talk to the study team

Nicolás Moreno Mata MD, PhD, Medicine  ·  0034 647609363  ·  nicolas.moreno.hrc@gmail.com

Always discuss trial participation with your own doctor first.

Locations (5)

Hospital de CrucesCruces, Basque Country, SpainRecruiting
Complejo Hospitalario Universitario InsularLas Palmas de Gran Canaria, Canary Islands, SpainRecruiting
Hospital Universitario Josep TruetaBarcelona, Catalonia, SpainRecruiting
Hospital Universitario Ramón y CajalMadrid, Madrid, SpainRecruiting
Hospital Universitario de La RiberaAlzira, Valencia, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07018960